Clinically-meaningful improvements in therapy for unresectable NSCLC

S Katakura, S Murakami - Expert Review of Anticancer Therapy, 2022 - Taylor & Francis
Introduction The ideal management of patients with unresectable non-small-cell lung cancer
(NSCLC) is still developing. Unresectable NSCLC has a high mortality rate and poor …
被引用次数：5 相关文章

Clinically-meaningful improvements in therapy for unresectable NSCLC.

S Katakura, S Murakami - Expert Review of Anticancer Therapy, 2022 - europepmc.org
The ideal management of patients with unresectable non-small-cell lung cancer (NSCLC) is
still developing. Unresectable NSCLC has a high mortality rate and poor prognosis. The …

Clinically-meaningful improvements in therapy for unresectable NSCLC

S Katakura, S Murakami - Expert review of anticancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The ideal management of patients with unresectable non-small-cell lung cancer
(NSCLC) is still developing. Unresectable NSCLC has a high mortality rate and poor …